跳至主要内容
临床试验/NCT03804931
NCT03804931招募中2 期

Efficacy and Safety of Fecal Microbiota Transplantation for Ulcerative Colitis

Guangzhou First People's Hospital1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2019年1月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
120
试验地点
1
主要终点
Clinical remission in patient as assessed using Mayo score

研究概览

简要总结

Fecal microbiota transplantation (FMT) is a strategy that infuses a fecal suspension containing a healthy donor's microbiota into a patient's gut to restore his/her intestinal microbiome. Fecal microbiota transplantation has been used for several disease,but the efficacy of ulcerative colitis(UC) by fecal microbiota transplantation needs to be further explored.The investigators propose to determine the efficiency and safety of FMT in patients with ulcerative colitis(UC).

详细描述

The present clinical trial aims to re-establish a gut functionality state of intestinal flora through FMT as a therapy for ulcerative colitis(UC). We established a standard microbiota isolation from donated fresh stool in lab. Then the microbiota is transplanted to the intestine. Patients from Guangzhou First People's Hospital in this study will be assigned to receive FMT at least two times according to associated guidelines and follow-up for at least three months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Active, moderate to severe severity (Mayo score more than 6)
  • Safety using history of 5-ASA
  • Able to undergo endoscopy examination

排除标准

  • Antibiotic using in 7 days
  • High risk of toxic megacolon
  • Colon cancer or neoplasia in pathophysiology
  • Other severe diseases (eg: cardiovascular, respiratory, gastroenteral and kidney diseases)

研究组 & 干预措施

Fecal microbiota transplantation

Experimental

Fecal microbiota transplantation

干预措施: Fecal microbiota transplantation (Procedure)

Fecal microbiota transplantation

Experimental

Fecal microbiota transplantation

干预措施: 5-Aminosalicylic acid(5-ASA) and/or Prednisone (Drug)

placebo fecal microbiota transplantation

Sham Comparator

Infusion of Saline

干预措施: Infusion of Saline (Procedure)

placebo fecal microbiota transplantation

Sham Comparator

Infusion of Saline

干预措施: 5-Aminosalicylic acid(5-ASA) and/or Prednisone (Drug)

Traditional treatments

Other

Drug:5-Aminosalicylic acid(5-ASA) and/or Prednisone

干预措施: 5-Aminosalicylic acid(5-ASA) and/or Prednisone (Drug)

结局指标

主要结局

Clinical remission in patient as assessed using Mayo score

时间窗: 12 weeks

Total Mayo score less than 2 and no signal item more than 1

Clinical improvement in patient as assessed using Mayo score

时间窗: 12 weeks

Total Mayo score decreased more than 3

次要结局

  • Intestinal microbiota changing(12 weeks)

研究者

发起方
Guangzhou First People's Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验